famili
bunyavirida
compris
larg
heterogen
group
arthropodborn
virus
certain
structur
featur
common
bishop
shope
bishop
et
virus
envelop
contain
two
surfac
glycoprotein
gl
intern
nucleocapsidassoci
protein
n
larg
intern
protein
l
believ
transcriptas
compon
nucleocapsid
consist
three
singlestrand
rna
genom
segment
l
basi
genet
recombin
sequenc
analysi
conclud
rna
encod
nucleocapsid
protein
n
nonstructur
protein
ns
rna
encod
two
glycoprotein
gl
genera
nonstructur
protein
ns
l
rna
probabl
contain
inform
viral
transcriptas
bishop
et
al
bouloy
et
cabradilla
et
al
collett
et
eshita
bishop
fuller
et
al
lhara
et
lee
et
al
ronnholm
pettersson
schmaljohn
et
request
reprint
address
also
demonstr
use
temperaturesensit
mutant
intracellular
accumul
glycoprotein
occur
absenc
viru
matur
gahmberg
er
lntracytoplasm
viru
bud
also
describ
coronavirus
duboisdalcq
eta
holm
et
al
tooz
et
tooz
tooz
flavivirus
leari
blair
torovirus
fagerland
et
weiss
horzinek
rotavirus
altenburg
et
al
petri
et
al
report
el
glycoprotein
coronavirus
express
clone
dna
accumul
intracellularli
macham
rose
rottier
rose
furthermor
evid
recent
report
indic
one
three
hydrophob
membranespan
domain
protein
respons
retent
golgi
complex
macham
rose
punta
toro
viru
ptv
one
arthropodborn
virus
assign
phlebotomu
fever
serogroup
phleboviru
genu
bunyavirida
bishop
et
structur
morpholog
featur
similar
member
famili
bunyavirida
rna
ptv
unusu
ambisens
code
strategi
one
protein
n
code
subgenom
viralcomplementari
mrna
speci
second
protein
nss
code
viral
sens
mrna
ihara
et
rna
segment
possess
singl
open
read
frame
viralcomplementari
sequenc
presum
code
polyprotein
precursor
addit
gi
glycoprotein
code
sequenc
sequenc
capabl
code
polypeptid
approxim
kda
found
preced
gi
code
sequenc
although
put
nsm
protein
product
correspond
sequenc
identifi
either
virion
infect
cell
estim
size
n
gl
predict
amino
acid
sequenc
da
respect
ihara
et
construct
vaccinia
viru
recombin
express
gl
glycoprotein
ptv
order
studi
possibl
exist
signal
intracellular
retent
bunyaviru
glycoprotein
report
express
two
glycoprotein
ptv
local
infect
cell
absenc
viral
compon
vero
maddoneta
maintain
dulbecco
modifi
eagl
medium
dmem
supplement
newborn
bovin
serum
human
cell
maintain
medium
supplement
pgml
vaccinia
viru
stock
prepar
titrat
plaqu
assay
cell
ptv
stock
prepar
titrat
vero
cell
vaccinia
recombin
plasmid
contain
gl
glycoprotein
gene
dna
manipul
carri
describ
maniati
et
four
cdna
clone
previous
use
sequenc
analysi
clone
pstl
site
ihara
et
seri
restrict
digest
ligat
clone
fulllength
ptv
cdna
clone
construct
insert
promega
biotech
madison
wi
design
pgemm
found
howev
analysi
protein
synthesi
vitro
transcript
translat
system
use
pgemm
subsequ
sequenc
analysi
pgemm
contain
delet
mutat
middl
gl
glycoprotein
code
region
also
found
sequenc
preced
gl
code
sequenc
seem
inhibitori
effect
growth
bacteri
coloni
problem
preced
gl
code
region
remov
digest
exonucleas
order
repair
mutat
ncolxbal
restrict
fragment
contain
mutat
region
replac
correspond
fragment
clone
one
origin
clone
use
sequenc
analysi
fig
transform
coloni
select
two
clone
obtain
one
contain
fragment
begin
nucleotid
residu
atg
nucleotid
residu
wherea
contain
fragment
begin
residu
lack
initi
codon
synthesi
g
glycoprotein
clone
contain
atg
codon
region
preced
g
code
sequenc
design
pgemg
c
sinc
possess
c
residu
posit
upstream
translat
initi
site
clone
atg
sequenc
modifi
introduc
translat
initi
codon
digest
ecori
treatment
klenow
dna
polymeras
cal
linker
ad
end
dna
order
provid
atg
sequenc
segment
digest
cal
treat
klenow
polymeras
follow
digest
either
pstl
sali
order
remov
plasmid
sequenc
segment
insert
either
digest
treat
klenow
polymeras
follow
pstl
digest
digest
xbal
treat
klenow
polymeras
follow
sali
digest
result
pgemg
contain
residu
posit
initi
codon
pgemg
g
g
residu
posit
obtain
fig
ptv
glycoprotein
gene
excis
barnhi
three
clone
pgemg
c
pgemg
pgemg
g
treat
klenow
polymeras
insert
smal
site
vaccinia
recombin
plasmid
chakrabarti
et
vaccinia
recombin
plasmid
contain
influenza
ha
gene
cdna
clone
wsnha
gene
kindli
provid
dr
debi
nayak
ha
gene
excis
reclon
pstl
site
stephen
et
al
plasmid
liniar
bamhl
digest
treat
exonucleas
remov
dg
dc
homopolymer
tail
end
treat
klenow
dna
polymeras
digest
hindil
ha
gene
fragment
separ
vector
insert
hindillhinclldigest
excis
byxbalhindil
digest
treat
klenow
dna
polymeras
insert
smal
site
select
recombin
cell
infect
pfu
tkvaccinia
viru
presenc
budr
pgml
hr
infect
monolay
overlay
lowmeltingpoint
agaros
contain
pgml
xgal
hr
blue
plaqu
pick
purifi
two
addit
round
plaqu
purif
hyperimmun
mous
ascit
fluid
specif
ptv
monoclon
antibodi
gl
glycoprotein
kindli
provid
dr
j
f
smith
pifat
usamriid
petrick
md
rabbit
antiserum
influenza
viru
prepar
describ
elsewher
roth
compan
cell
hela
cell
infect
vaccinia
viru
recombin
ptv
moi
hr
pi
cell
wash
phosphatebuff
salin
pb
incub
methioninefre
medium
hr
hr
pi
cell
label
methionin
iml
methioninefre
medium
hr
pulsechas
experi
cell
puls
min
chase
eagl
medium
contain
mlvl
methionin
appropri
period
cell
wash
three
time
icecold
pb
lyse
ml
lysi
buffer
mm
trishci
ph
naci
oo
triton
xl
oh
sd
mm
edta
nuclei
remov
centrifug
g
min
cell
lysat
incub
cl
mous
ascit
ptv
hr
constant
mix
immunoprecipit
cellsurfac
antigen
antibodi
ad
cell
lyse
incub
min
ice
wash
remov
unbound
antibodi
radiolabel
polypeptid
immunoprecipit
protein
asepharos
pharmacia
inc
piscataway
nj
precipit
wash
three
time
cold
lysi
buffer
resuspend
sampl
buffer
boil
min
analyz
sdspolyacrylamid
gel
laemmli
hela
label
period
pmsf
tm
maintain
medium
treat
cell
half
sampl
treat
endo
h
hr
lane
b
f
h
j
sampl
analyz
sdspage
laboratori
inc
san
mateo
ca
experi
cell
wash
pb
mount
observ
nikon
optiphot
microscop
equip
modifi
cube
h
digest
lmmunoprecipit
sampl
boild
min
sdspage
sampl
buffer
protein
asepharos
remov
supernat
dilut
sodium
acet
ph
incub
hr
presenc
muml
endoglycosidas
h
endo
h
boehringermannheim
biochem
indianapoli
mm
pmsf
sampl
precipit
looh
tca
hr
wash
cold
ethanoleth
l
resuspend
sdspage
analysi
quantit
antigen
express
cell
surfac
surfac
radioimmunoassay
perform
method
describ
stephen
er
al
hela
cell
glass
coverslip
infect
vaccinia
viru
vaccinia
viru
recombin
moi
appropri
time
infect
cell
wash
three
time
pbsl
bovin
serum
albumin
bsa
overlaid
antibodi
dilut
pbsl
bsa
incub
min
cell
wash
three
time
pbsl
bsa
incub
cpm
amersham
arlington
height
il
prepar
pbsiso
bsa
min
room
temperatur
label
remov
cell
wash
three
time
pbsl
bsa
bound
radioact
determin
nonspecif
bind
cell
infect
wildtyp
vaccinia
viru
determin
antisera
subtract
valu
compar
level
plv
glycoprotein
synthesi
monolay
cell
infect
wildtyp
vaccinia
viru
ptv
vaccinia
recombin
describ
contain
ptv
glycoprotein
gene
differ
sequenc
translat
initi
region
hr
pi
cell
label
hr
methionin
harvest
immunoprecipit
two
polypeptid
electrophoret
mobil
similar
gl
glycoprotein
synthes
ptvinfect
cell
precipit
cell
infect
vaccinia
recombin
use
antibodi
specif
ptv
fig
polypeptid
correspond
glycoprotein
occasion
appear
doublet
appear
lower
band
consist
observ
may
differ
glycosyl
form
glycoprotein
similar
observ
synthesi
heterogen
hantaan
htn
gl
glycoprotein
report
pensiero
et
level
protein
synthesi
much
higher
recombin
contain
g
translat
initi
posit
one
contain
c
therefor
one
recombin
contain
g
posit
chosen
prototyp
design
vvg
use
experi
effect
tunicamycin
tm
synthesi
protein
also
examin
shown
fig
hr
pi
cell
infect
ptv
recombin
expos
medium
contain
tm
hr
cell
label
methionin
hr
lyse
immunoprecipit
gl
glycoprotein
synthes
vvg
recombin
eitherth
presenc
absenc
tm
show
slightli
slower
mobil
gel
synthes
ptvinfect
cell
glycoprotein
appear
multipl
band
presenc
tm
may
indic
partial
inhibit
glycosyl
amount
gl
glycoprotein
detect
presenc
tm
significantli
lower
absenc
tm
contrast
condit
glycosyl
influenza
ha
glycoprotein
complet
inhibit
similar
amount
glycosyl
unglycosyl
form
ha
detect
higher
concentr
tm
pgml
use
neither
gl
glycoprotein
detect
data
shown
therefor
unglycosyl
form
gl
glycoprotein
appear
rel
unstabl
quickli
degrad
even
presenc
pmsf
intracellular
local
express
glycoprotein
examin
hela
cell
cell
line
show
minim
cytopath
effect
vaccinia
viru
infect
compar
cell
line
therefor
well
suit
studi
protein
local
r
owen
r
compan
submit
public
hela
cell
infect
vvg
recombin
hr
pi
cell
fix
examin
use
indirect
immunofluoresc
microscopi
protein
express
vvg
local
perinuclear
region
coincid
region
stain
wheat
germ
agglutinin
marker
golgi
complex
fig
b
recombin
vvginfect
cell
also
treat
cycloheximid
determin
whether
gl
glycoprotein
chase
golgi
region
shown
fig
glycoprotein
retain
golgi
region
chase
cycloheximid
accumul
protein
local
region
cytoplasm
much
appar
cycloheximidetr
cell
e
f
compar
cell
treatment
c
order
investig
intracellular
locat
glycoprotein
process
oligosaccharid
side
chain
studi
treatment
endo
h
puls
label
vvginfect
cell
variou
chase
period
protein
immunoprecipit
digest
endo
h
fig
gl
synthes
vvg
recombin
acquir
endo
h
resist
within
chase
period
suggest
contain
complextyp
oligosaccharid
side
chain
glycoprotein
hand
appear
contain
high
mannosetyp
complexor
intermediatetyp
sugar
moieti
result
indic
gl
glycoprotein
transport
rer
golgi
complex
matur
oligosaccharid
take
place
signific
amount
surfac
express
viral
glycoprotein
observ
cell
infect
ptv
vvg
examin
surfac
immunofluoresc
fig
f
contrast
vaccinia
recombin
express
influenza
ha
glycoprotein
shown
control
exhibit
typic
surfac
protein
express
fig
lack
signific
surfac
expresison
ptv
glycoprotein
also
examin
two
biochem
approach
hr
pi
cell
infect
wg
recombin
puls
min
methionin
chase
medium
contain
excess
cold
methionin
min
presenc
protein
cell
surfac
analyz
surfac
immun
precipit
shown
fig
lane
fj
faint
band
seen
surfac
immunoprecipit
increas
intens
gl
protein
seen
chase
indic
protein
transport
cell
surfac
time
period
also
confirm
ascit
fluid
specif
ptv
possess
viru
neutral
activ
henc
abil
react
extracellular
form
plv
glycoprotein
data
shown
order
determin
whether
plv
glycoprotein
secret
supernat
wginfect
cell
cultur
examin
hr
pi
infect
cell
label
methioninefor
hr
protein
present
cultur
media
immunoprecipit
analyz
sdspage
detect
amount
gl
glycoprotein
found
medium
data
shown
cellsurfac
express
also
quantit
bind
assay
differ
time
point
infect
vaccinia
recombin
express
ha
use
control
surfac
express
shown
fig
ha
detect
cell
surfac
hr
pi
amount
increas
hr
pi
contrast
ptv
glycoprotein
bare
detect
hr
pi
level
maximum
bind
significantli
lower
observ
ha
throughout
experi
signific
cytopath
effect
observ
percentag
live
cell
recombinantinfect
cultur
determin
trypan
blue
stain
uninfect
cell
construct
vaccinia
viru
recombin
contain
partial
cdna
clone
genom
segment
ptv
encod
gl
glycoprotein
although
complet
segment
clone
initi
obtain
mutat
gl
glycoprotein
gene
appar
inhibitori
effect
sequenc
preced
gl
glycoprotein
gene
bacteri
growth
interf
attempt
repair
mutat
preced
gl
code
sequenc
elimin
obtain
glycoprotein
express
recombin
viru
wg
effici
produc
two
polypeptid
recogn
antibodi
ptv
suggest
two
glycoprotein
bunyavirus
includ
ptv
deriv
larg
precursor
protein
follow
proteolyt
cleavag
collett
et
eshita
bishop
lhara
el
although
precursor
molecul
glycoprotein
never
identifi
virusinfect
cell
produc
vitro
translat
system
use
mrna
isol
uukuniemi
virusinfect
cell
ulmanen
et
al
vvg
recombin
produc
two
glycoprotein
similar
size
gl
ptvinfect
cell
suggest
cleavag
gl
occur
correctli
observ
howev
use
tunicamycin
tm
unglycosyl
form
g
synthes
recombin
slightli
higher
molecular
weight
ptvinfect
cell
sinc
one
predict
gli
hr
pi
hela
cell
infect
wg
label
methionin
min
lane
f
chase
min
lane
b
g
min
lane
c
h
min
lane
min
lane
e
j
medium
contain
mm
unlabel
methionin
cell
lyse
react
antiptvascit
fluid
lane
b
c
e
treat
antiptv
ascit
fluid
lyse
lane
f
g
h
j
follow
immunoprecipit
radiolabel
polypeptid
analyz
sdspage
cosyl
site
found
gl
glycoprotein
sequenc
includ
extra
short
sequenc
end
wg
ihara
et
like
decreas
size
gl
glycoprotein
presenc
tm
reflect
complet
inhibit
glycosyl
also
appar
molecular
weight
unglycosyl
form
gl
glycoprotein
ptv
infect
cell
correspond
size
predict
sequenc
analysi
da
observ
differ
size
kda
unglycosyl
gl
ptv
wg
may
therefor
correspond
extra
amino
acid
preced
gl
glycoprotein
deriv
put
ns
code
region
case
cleavag
gl
partial
nsm
sequenc
may
take
place
although
seem
consensu
sequenc
alanin
potenti
cleavag
site
put
precursor
protein
ptv
well
rift
valley
fever
viru
rvfv
ihara
et
collett
et
present
result
indic
addit
factor
secondari
structur
protein
may
also
necessari
proper
cleavag
uncleav
precursor
protein
detect
either
ptvor
recombinantinfect
cell
presenc
proteas
inhibitor
andor
tm
therefor
glycosyl
appar
essenti
cleavag
ptv
glycoprotein
seem
contain
necessari
inform
intracellular
local
well
major
protein
produc
vvg
recombin
remain
intracellularli
thorughout
infect
period
intracellular
locat
glycoprotein
examin
digest
protein
endo
h
gener
consid
time
requir
acquisit
endo
h
resist
correspond
transport
time
rer
golgi
complex
strou
lodish
find
endo
h
resist
form
gl
glycoprotein
indic
glycoprotein
transport
rer
golgi
complex
furthermor
hr
treatment
cycloheximid
glycoprotein
still
local
golgi
region
immunofluoresc
indic
protein
retain
golgi
complex
late
time
postinfect
small
amount
protein
detect
cell
surfac
bind
assay
immunofluoresc
sinc
glycoprotein
retain
golgi
region
hr
presenc
cycloheximid
transport
golgi
complex
cell
surfac
must
extrem
slow
take
place
cellsurfac
express
small
amount
glycoprotein
also
report
bunyavirus
kuismanen
et
madoff
lenard
gahmberg
et
howev
protein
may
present
cellassoci
virion
smith
pifat
schmaljohn
eta
unlik
ptv
rvfv
htn
genom
segment
lack
sequenc
may
encod
anoth
protein
instead
possess
amino
acid
follow
first
atg
segment
preced
gl
glycoprotein
may
simpli
act
signal
peptid
result
well
present
observ
indic
glycoprotein
bunyaviru
synthes
process
local
properli
without
requir
viral
compon
viral
nucleocapsid
viruscod
nonstructur
protein
precis
locat
glycoprotein
signal
intracellular
retent
remain
determin
recent
studi
el
glycoprotein
coronaviru
macham
rose
indic
role
hydrophob
sequenc
protein
retent
delet
one
hydrophob
membran
span
domain
glycoprotein
normal
retain
intracellular
membran
result
secret
transport
surfac
interest
carri
similar
studi
determin
precis
retent
signal
ptv
glycoprotein
